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O B J E C T I V E S The aim of this study was to investigate the effects of surgical ventricular
reconstruction (SVR) on cardiac efﬁciency as a surrogate marker for cardiac function and oxidative
metabolism in patients with severe heart failure.
B A C KG ROUND Our new integrated overlapping left ventriculoplasty, modiﬁed SVR, combined with
mitral complex reconstruction, reduce left ventricular (LV) volume associated with improvement of symptoms
of heart failure.
METHOD S Twelve consecutive patients with end-stage heart failure due to nonischemic dilated
cardiomyopathy (DCM) (n  6) and ischemic dilated cardiomyopathy (ICM) (n  6) who underwent SVR
were studied. Myocardial oxidative metabolism per gram of tissue was estimated by monoexponential
clearance of 11C-acetate positron emission tomography (Kmono). Forward stroke volume at the LV
outﬂow tract was measured by echocardiography. Cardiac efﬁciency was estimated by the ratio of
external work (stroke volume at the LV outﬂow tract index  systolic blood pressure  heart rate) to
Kmono before and 1 month after SVR.
R E S U L T S After SVR, medians of New York Heart Association functional class signiﬁcantly improved
from 3 to 1.5 (p  0.01) in both DCM and ICM patients. End-systolic and end-diastolic volume and LV
mass signiﬁcantly decreased in both groups. Stroke volume at the LV outﬂow tract increased from 43 
8 ml to 52  11 ml (p  0.028) in DCM patients, but not in ICM patients (49  21 ml to 59  26 ml,
p  0.12). Kmono  LV mass, as an index of global LV oxidative metabolism, decreased in DCM patients
(13.6  1.9 g/min vs. 8.6  1.5 g/min, p  0.03) and ICM patients (12.0  3.4 g/min vs. 9.2  1.0 g/min,
p 0.06). As a result, cardiac efﬁciency increased in all patients with DCM (3.34 0.46 10E6 vs. 4.74
0.88 10E6 mm Hg·ml·min/m2, p 0.03) and in 5 of 6 patients with ICM (4.54 1.66 10E6 vs. 5.99
2.11  10E6 mm Hg·ml·min/m2, p  0.12).
CONC L U S I O N S Combined surgery with SVR and mitral complex reconstruction reduced LV volume
in association with improvement of cardiac efﬁciency in patients with severe heart failure. (J Am Coll Cardiol
Img 2011;4:762–70) © 2011 by the American College of Cardiology Foundation
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763ecent advances in medical treatment includ-
ing angiotensin-converting enzyme inhibi-
tors and -blockers as well as cardiac resyn-
chronization therapy have been shown to be
ffective at improving the symptoms and progno-
is in patients with severe heart failure (1–3).
espite these standard therapies, the mortality
ate in these patients is still high. Heart trans-
lantation is the most effective surgical treatment
or patients with refractory heart failure. The
See page 771
shortage of the donor hearts has necessitated the
development of alternatives such as surgical ventric-
ular reconstruction (SVR). We developed overlap-
ping left ventriculoplasty (OLVP), modified SVR
without resection of left ventricular (LV) muscle,
and mitral complex reconstruction (MCR), which
have been shown to improve the symptoms in
end-stage heart failure patients (4,5).
Noninvasive qualitative assessment of myocardial
oxidative metabolism is possible by using 11C-
cetate as a metabolic tracer with positron emission
omography (PET). 11C-Acetate is taken up by the
myocardium, and the subsequent monoexponential
clearance rate of 11C-acetate from the myocardium
(Kmono) correlates well with the myocardial oxygen
emand (6). The work metabolic index (WMI), as
ssessed by external work per myocardial oxidative
etabolism, has been used as an index of cardiac
fficiency (7–9).
LV remodeling, the dilation of the LV cavity
ith a spherical shape, is commonly seen in patients
ith severe heart failure due to ischemic dilated
ardiomyopathy (ICM) as well as nonischemic
ilated cardiomyopathy (DCM) (10). In addition,
oncomitant mitral regurgitation reduces forward
xternal work and further increases LV dilation due
o volume overload (10). These hemodynamic fea-
ures of a remodeled left ventricle produce increased
all stress associated with increased oxygen de-
and, low output, and low cardiac efficiency
8,9,11). Importantly, -blockers, cardiac resyn-
hronization therapy, and the correction of mitral
egurgitation have been demonstrated to improve
ardiac efficiency assessed by using PET (7,11).
Our surgery integrated with SVR and MCR can
educe LV volume and correct LV shape, which can
educe LV wall stress. However, the effects of our
urgery on cardiac oxidative metabolism and effi-
iency have not been elucidated. Furthermore, the
ifference in its effects on the etiologies of heart lailure is unknown. We thus determined whether
VR could improve cardiac efficiency in patients
ith severe heart failure due to ICM and DCM by
sing PET and 11C-acetate.
M E T H O D S
We studied 12 consecutive patients (age 59  10
years) at the Department of Cardiovascular Surgery,
Hokkaido University Hospital, Sapporo, Japan.
The study patients had heart failure symptoms with
New York Heart Association (NYHA)
functional class III or IV and an LV
ejection fraction (LVEF) 40%. The
causes of heart failure were DCM in 6
patients and ICM in 6 patients. Patients
under continuous infusion of positive ino-
tropes and who had an LV aneurysm due
to previous myocardial infarction were ex-
cluded. Patients who had significant cor-
onary artery stenosis (50%) as assessed
by invasive coronary angiography had a
diagnosis of ICM, and patients who had
no known coronary artery stenosis or rec-
ognized etiology by myocardial biopsy re-
ceived a diagnosis of DCM. The study was
approved by the institutional ethics board of
the Hokkaido University Graduate School
of Medicine. Written informed consent was
obtained from each patient. Each patient
received the standard medical treatment for
severe heart failure (Table 1). Three patients
had diabetes mellitus and were effectively
treated with sulfonylurea (n  2) and acar-
bose (n  1). -blockers were discontinued
o avoid the worsening of heart failure dur-
ng the perioperative period (for 1 month),
s previously described (12). Other medical
herapy except -blockers was adjusted by
physicians according to the patients’ volume
status and blood pressure.
Operative procedure. OLVP is an SVR
hat we previously developed (Fig. 1A). In patients
ndergoing OLVP, the left ventricle was incised
rom the apex basally to the diagonal artery along
he left anterior descending artery at a distance of
or 2 cm. The lateral margin was then folded and
utured to the interventricular septum with inter-
upted mattress and continuous sutures using felt
trips. The suture line was determined using
ntraventricular sizers. After suturing the lateral
argin, the septal margin was then sutured onto the
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764patients or over the free LV wall in DCM patients,
resulting in the overlap of myocardial walls in the
anteroseptal lesion. This procedure has advantages
such as preserving cardiac muscle and the circum-
flex coronary artery without resection of the left
ventricle compared with traditional SVR. More
importantly, this technique can alter the dilated
spherical left ventricle to the appropriate elliptical
shape (4,5,12).
MCR is mitral annuloplasty that includes papil-
lary muscle approximation and papillary muscle
suspension, which is effective in treating mitral
regurgitation caused by tethering of mitral leaflets
(Fig. 1B). Papillary muscle approximation has been
already proven to be an effective procedure to
reduce the tethering of the mitral leaflets and to
suspend the tips of papillary muscles from mitral
annulus, helping to prevent future deterioration of
tethering (4,5,12).
Measurement of oxidative metabolism by 11C-
acetate PET and echocardiographic studies were
performed in all patients before and 1 month after
surgery. All patients underwent 11C-acetate PET
can and echocardiography within a week of each
ther.
Myocardial oxidative metabolism by 11C-acetate PET.
PET was performed using a whole-body scanner
(ECAT/EXACT HR, Siemens/CTI, Knoxville,
Tennessee). A total of 740 MBq of 11C-acetate was
administered intravenously for 60 s under resting
conditions, and dynamic PET was performed (10
10 s, 1  60 s, 5  100 s, 3  180 s, 2  300 s).
ET data analysis was performed using dedicated
oftware (9). The images were iteratively recon-
acteristics and Surgical Procedures
) Sex Diagnosis Procedure
M DCM, MR, Af OLVP, MAP, RF maze
M DCM, MR, AR, TR, p/o CRT OLVP, MAP, PMA, TAP, AVR
F DCM, MR, TR, Af OLVP, MCR, TAP, RF maze
M DCM, MR, TR, pAf OLVP, MCR, TAP, pulmona
M DCM, MR, TR Linear closure, MCR, TAP
M DCM, MR, pAf OLVP, MCR
M ICM, MR, TR, p/o CRT OLVP, CABG, MCR, TAP
M ICM, MR, TR OLVP, CABG, MCR, TAP
M ICM, MR, TR, Af OLVP, CABG, MCR, TAP, RF
M ICM, MR, TR Linear closure, CABG, MCR
M ICM, MR, TR OLVP, MCR, TAP
M ICM, p/o CRT OLVP, CABG, PMA
on; AR  aortic regurgitation; ARB  angiotensin receptor blocker (includes renin-a
ary artery bypass grafting; CRT cardiac resynchronization therapy; DCM nonische
ale; MCR  mitral complex reconstruction; MR  mitral regurgitation; OLVP  overla
-operation; RF maze  radiofrequency maze; SVR  surgical ventricular reconstructiotructed and resliced along the short axis. Blood rressure and heart rate were monitored during PET
o calculate a rate-pressure product.
To compute a semiquantitative summed rest
erfusion score of 11C-acetate perfusion imaging in
the early phase (5 min), a standard 17-segment,
5-point scoring system (0  normal uptake, 1 
mild defect, 2moderate defect, 3 severe defect,
and 4  absent tracer uptake) was used.
Cardiac oxidative metabolism per gram of tissue
was determined from the monoexponential clear-
ance rate of 11C-acetate (Kmono), as previously
escribed (9). To calculate the LV mass (LVM),
he volume within the region of interest was com-
uted by using dedicated software.
Echocardiography. Echocardiographic examination
as performed by an experienced cardiologist or
onographers, and 2 experienced cardiologists re-
iewed their findings without knowledge of the
ET data. Left ventricular end-diastolic volume
LVEDV), LV end-systolic volume (LVESV), and
VEF were measured from apical 2-chamber and
-chamber views using the biplane disk-summation
ethod according to American Society of Echocardi-
graphy Committee recommendations. Forward
troke volume was measured with pulsed-wave Dopp-
er imaging on the LV outflow tract (SVLVOT). Mitral
regurgitation was graded by using color flow Doppler
imaging according to American Heart Association/
American College of Cardiology guidelines (13).
Global oxidative metabolism and WMI. Global car-
iac oxidative metabolism was calculated by multi-
lying Kmono by the LVM. External work per
inute was calculated by the following equation:
VLVOT index  systolic blood pressure  heart
Medications at Baseline
Diuretic, spironolactone, amiodarone
-blocker, ARB, diuretic, spironolactone
ARB, diuretics, spironolactone
in isolation -blocker, ARB, diuretics, amiodarone, sulfonylurea
-blocker, ARB, diuretics, sulfonylurea
-blocker, ARB, diuretics, spironolactone
-blocker, spironolactone
-blocker, ARB, diuretic, spironolactone
ze -blocker, diuretic
P -blocker, ARB, diuretic, spironolactone
ARB, diuretic, acarbose
-blocker, ARB, diuretics
tensin blocker and angiotensin-converting enzyme inhibitor); AVR  aortic valve
ilated cardiomyopathy; F female; ICM ischemic cardiomyopathy; MAPmitral
left ventriculoplasty; pAf  paroxysmal atrial ﬁbrillation; PMA  papillary muscle
P  tricuspid valve annuloplasty; TR  tricuspid regurgitation.Table 1. Patient Char
Patient # Age (yrs
1 55
2 64
3 60
4 69 ry ve
5 77
6 37
7 50
8 55
9 62 ma
10 60 , TA
11 63
12 52
Af  chronic atrial ﬁbrillati ngio
replacement; CABG coron mic d
valve annuloplasty; M  m ppingate at resting condition. The WMI was calcu-
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765lated as an index of cardiac efficiency by dividing
external work per minute by Kmono, as previously
escribed (7,8).
Statistical analysis. All measurements were ex-
ressed as mean  SD. Baseline characteristic data
ere compared by an unpaired t test between DCM
nd ICM patients. Baseline and follow-up data
ere compared by Wilcoxon single-rank tests. A p
alue 0.05 was considered a statistically signifi-
ant difference.
R E S U L T S
Baseline characteristics. There were no operative
deaths. All patients underwent SVR (OLVP in 10
patients and linear closure in 2 patients) (Table 1).
As concomitant procedures, MCR was performed
in 9 patients and mitral valve annuloplasty in 2
patients, maze procedures for chronic atrial fibril-
lation in 3 patients, pulmonary vein isolation for
paroxysmal atrial fibrillation in 1 patient, tricuspid
valve annuloplasty for tricuspid regurgitation in 9
patients, and coronary artery bypass grafting for
coronary artery disease in 5 of 6 ICM patients.
Table 2 shows the baseline characteristics of the
study patients. Before surgery, 10 patients were
classified as NYHA functional class III and 2
patients as functional class IV. Marked LV dilation
and severe mitral regurgitation were observed in 11
of 12 patients. The average LVEF was 25% and the
average SVLVOT was 46 ml.
Table 3 shows the baseline characteristics of
subgroups of patients according to DCM and ICM.
When the baseline characteristics were compared
between groups, heart rate (p  0.029) and rate-
pressure product (p  0.001) were significantly
lower in DCM patients than in ICM patients.
LVEDV, LVESV, LVEF, and SVLVOT did not
differ between groups. The degree of mitral regur-
gitation tended to be greater in patients with DCM
than in those with ICM (p  0.076).
On 11C-acetate PET data analysis, the summed
rest perfusion score was 10.3  6.7 in all patients,
nd there was no significant difference between
CM patients and ICM patients (7.0  4.2 vs.
3.7  7.4, p  0.09). The LVM did not differ
between DCM patients and ICM patients (300 
41 vs. 248  58 g, p  0.11). Kmono and Kmono 
LVM were comparable between patients with
DCM and ICM (Kmono: 0.045 0.003 vs. 0.048
0.007 /min, p  0.37; Kmono  LVM: 13.6  1.9
s. 12.0  3.4 g/min, p  0.37). The WMI tended
o be lower in DCM patients than in ICM patients K3.34  0.46  106 vs. 4.54  1.66  106 mm Hg·
ml/m2, p  0.14), which, however, did not reach
tatistical significance.
Effects of SVR on cardiac function and efﬁciency. After
surgery, NYHA functional class was significantly
improved in the study patients. Systolic blood
pressure significantly decreased and heart rate sig-
nificantly increased (Table 2). The rate-pressure
product tended to be increased, which, however,
did not reach statistical significance. LVEDV and
LVESV significantly decreased in relation to the
increase in SVLVOT. Mitral regurgitation was de-
reased to minimal. Pulmonary artery systolic pres-
ure significantly decreased. LVM significantly de-
reased from 274 55 g to 191 32 g (p 0.001).
Figure 1. Scheme of Surgery
Procedure of overlapping left ventricular reconstruction (A) and mit
plex reconstruction (B). In addition to mitral annuloplasty and papi
cle approximation (red arrow, upper middle image), papillary mus
suspension (red arrow, upper right image) is performed.ral com-
llary mus-
clemono did not change, whereas Kmono  LVM
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766significantly decreased (p  0.001) and the WMI
ignificantly increased (p 0.015) after SVR (Fig. 2).
When the effects of surgery were compared
etween groups, systolic blood pressure significantly
ecreased in ICM patients, but not in DCM
atients (Table 3). Heart rate was significantly
Table 2. Patient Characteristics Before and 1 Month After
Integrated SVR in All Patients
Variables
All Patients (N  12)
Before After p Value
NYHA functional class,
median
3 1.5 0.01
Hemodynamics
Systolic BP (mm Hg) 102 16 93 9 0.011
Diastolic BP (mm Hg) 58 12 59 11 0.91
Heart rate, beats/min 69 12 83 18 0.01
RPP, mm Hg  min1 6,987 1,416 7,635 1,584 0.084
Echocardiographic
ﬁndings
LVEDV, ml 241 76 150 38 0.01
LVESV, ml 174 52 106 35 0.01
LVEF, % 25 7 30 6 0.20
Forward SV, ml 46 15 56 19 0.019
Mitral regurgitation 3.5 0.9 0.6 0.5 0.01
Tricuspid
regurgitation
1.8 0.8 0.9 0.9 0.021
PASP* 52 15 41 12 0.028
Values are mean  SD or median. *PASP data were available in all nonisch-
emic dilated cardiomyopathy patients and in 4 of 6 ischemic dilated
cardiomyopathy patients.
BP  blood pressure; LVEDV  left ventricular end-diastolic volume; LVEF 
left ventricular ejection fraction; LVESV  left ventricular end-systolic volume;
NYHA  New York Heart Association; PASP  pulmonary artery systolic
pressure; RPP  rate-pressure product; SV  stroke volume; SVR  surgical
ventricular reconstruction.
Table 3. Patient Characteristics Before and 1 Month After Integ
Variables
DCM (n  6)
Before After
NYHA functional class, median 3 1.5
Hemodynamics
Systolic BP, mm Hg 95 9 91 7
Diastolic BP, mm Hg 52 11 55 9
Heart rate, beats/min 62 8 73 13
RPP, mm Hg  min1 5,853 817 6,581 1,23
Echocardiographic ﬁndings
LVEDV, ml 263 79 168 43
LVESV, ml 189 51 125 40
LVEF, % 24 7 26 5
Forward SV, ml 43 8 52 11
Mitral regurgitation 4.0 0.0 0.8 0.4
Tricuspid regurgitation 1.8 1.0 1.3 1.0
PASP* 50 17 40 16
Values are mean  SD or median. *PASP data were available in all DCM patien
Abbreviations as in Table 2.increased in both groups. The rate-pressure product
did not change in either group. LVESV and
LVEDV by echocardiography significantly de-
creased in both groups. LVEF did not change in
either group. SVLVOT significantly increased in
CM patients, but not in ICM patients (Table 3).
VM was significantly decreased in both DCM
atients (to 191  27 g, p  0.001) and ICM
atients (to 190  40 g, p  0.003). Kmono did not
change in either group, whereas Kmono LVM was
ignificantly decreased in patients with DCM (p 
.03) and tended to be decreased in patients with
CM (p  0.06). The WMI increased in all DCM
atients and in 5 of 6 ICM patients (Fig. 2). Figure 3
hows a representative case.
D I S C U S S I O N
The present study demonstrated that our new
surgery integrating OLVP and MCR reduced LV
volume and corrected the mitral regurgitation in
end-stage heart failure patients with DCM and
ICM. These surgical procedures may successfully
aid in increasing the cardiac efficiency associated
with the increase in forward external work and the
reduction of global myocardial oxidative metabo-
lism.
Effects of SVR and MCR on cardiac oxidative metabolism
and efﬁciency. OLVP is a modified SVR technique
without endoventricular patching and resection of
viable myocardium. MCR with papillary muscle
approximation and suspension is the most appro-
priate procedure for correcting tethered mitral valve
d SVR in Patients With DCM and ICM
ICM (n  6)
p Value Before After p Value
0.024 3 1.5 0.023
0.25 109 18 95 10 0.028
0.60 65 8 63 12 0.75
0.043 76 11 93 17 0.027
0.17 8,120 812 8,688 1,158 0.35
0.028 219 74 131 24 0.028
0.027 159 53 87 17 0.028
0.92 27 8 34 3 0.17
0.028 49 21 59 26 0.12
0.020 3.0 1.1 0.3 0.5 0.026
0.28 1.8 0.8 0.5 0.5 0.038
0.17 55 12 43 4 0.066
nd in 4 of 6 ICM patients.rate
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767and maintaining the elliptical LV shape (4,5,12).
We previously demonstrated that OLVP and MCR
improved NYHA functional class, and the 1- and
3-year actuarial survival rates were 91% and 87%,
respectively. The beneficial effects of OLVP and
MCR on cardiac efficiency may contribute to a
better outcome.
In the present study, the beneficial effects of
SVR on the hemodynamics and echocardio-
graphic findings were demonstrated. SVLVOT
increased only in DCM patients, which might be
due to the greater degree of mitral regurgitation
in DCM than ICM because the correction of
mitral regurgitation by MCR can reduce volume
overload in these patients.
Cardiac oxidative metabolism and efficiency have
been used as a surrogate marker of cardiac dysfunc-
tion and failure (8). Dilated LV is associated with a
greater wall stress and oxygen demand. Further-
more, the spherical LV shape is not effective for
increasing cardiac output. In fact, as previously
described (8), the WMI was decreased in dilated
Figure 2. Kmono, Kmono  LVM, and Work Metabolic Index Befo
Monoexponential clearance rate of 11C-acetate from the myocardiu
index (WMI) before and after surgery. Effects of the surgery on Kmono
opathy (DCM) (n  6, red circles) and ICM (n  6, green circles). A
LVM was signiﬁcantly decreased in patients with DCM and tended
patients with DCM and in 5 of 6 patients with ICM.cardiomyopathy. In the present study, the observedWMI before surgery was extremely low (3.94 
1.32  106 mm Hg·ml·min/m2) compared with
hat of a previous study (5.31  2.15  106 mm
Hg·ml·min/m2) in patients with LV dysfunction
(LVEF  31%) by Beanlands et al. (7), suggesting
that our study population had more severe heart
failure associated with poor cardiac efficiency.
Although oxidative metabolism was impaired in
dysfunctional LV with myocardial infarction and
remodeled LV associated with mitchondorial dys-
function (8,9), LV oxidative metabolism did not
differ between ICM and DCM patients in the
present study. The reason for the relative preserva-
tion of oxidative metabolism in ICM compared
with DCM may be due to the comparable scar area
in DCM and ICM because the patients with an LV
aneurysm were excluded from our study and the
semiquantitative myocardial perfusion score did not
differ between groups. After SVR, Kmono did not
change, suggesting that the anatomic changes in
LV volume and shape after SVR and MCR main-
tain the functional state of myocardial oxidative
nd After Surgery
mono), Kmono  left ventricular mass (LVM), and work metabolic
Kmono  LVM (B), and WMI (C) in patients with dilated cardiomy-
surgery, Kmono did not change in either group, whereas Kmono 
e decreased in patients with ICM. The WMI increased in allre a
m (K
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768accord with a previous study that found that cor-
rection of mitral regurgitation did not change
Kmono (11).
Previous studies demonstrated that advanced
edical therapies could improve hemodynamics,
ystolic function, myocardial oxidative metabolism,
nd their integrated index, cardiac efficiency, in
atients with heart failure (7,8,11). However, infor-
ation about the effects of SVR on cardiac effi-
iency has been limited. The STICH (Surgical
reatment for Ischemic Heart Failure) trial dem-
nstrated that SVR did not improve the prognosis
n addition to coronary artery bypass grafting in
atients with systolic dysfunction with an LVEF
35% (14), indicating that SVR could not improve
ardiac efficiency. However, it included only ICM
atients who needed coronary artery bypass grafting
Figure 3. Representative Patient Who Underwent Surgery
A representative case (Patient #2 in Table 2). Monoexponential clea
of Kmono before and after surgery (B) and
11C-acetate imaging (earl
(C). Kmono value did not change, whereas left ventricular size decrend only 14% patients had moderate to severe bitral regurgitation, whereas 11 of 12 patients
92%) in the present study had moderate to severe
itral regurgitation. In addition, their LVESV
ndex was 82 ml, whereas it was 104 ml in our
atients, suggesting that SVR might be more effec-
ive in patients with advanced LV remodeling and
evere mitral regurgitation.
We included various procedures in addition to
VR and MCR, such as tricuspid valve annulo-
lasty, the maze procedure, and coronary artery
ypass grafting. In particular, coronary artery bypass
rafting may potentially affect cardiac oxidative
etabolism in patients with ICM. However, their
xidative metabolism did not change after coronary
rtery bypass grafting in the present study, which
as extended the previous findings that myocardial
xidative metabolism at rest is preserved in ischemic
e rate of 11C-acetate for the myocardium (Kmono) (A). Polar map
ase) of short-axis view in the midlevel before and after surgery
after surgery.ranc
y phut viable myocardium (15). In addition, the effects
r
b
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769of tricuspid valve annuloplasty on the heart are
unknown because we did not measure Kmono in
ight ventricular wall. However, this procedure may
e less likely to affect oxidative metabolism in the
V wall.
Clinical implications. Low cardiac efficiency estimated
by the WMI might be expected to closely relate with
the progression of LV remodeling leading to cardiac
death. Consequently, a decrease in wall stress associ-
ated with the improvement of cardiac efficiency may
help to prevent the progression of LV remodeling over
time, which, however, needs to be investigated in the
larger population in the future.
SVR and MCR improved the WMI in all 6
patients with DCM and 5 of 6 patients with ICM,
indicating that our new combined procedure can be
used for both ischemic and nonischemic etiologies.
One patient had mild LV dilation (LVEDV, 151
ml and LVESV, 113 ml) associated with a relatively
preserved WMI (5.76  106 mm Hg·ml·min/m2),
which was higher by 46% than the average value.
This patient’s WMI decreased to 3.76  106 mm
Hg·ml/m2 with an LVEDV of 102 ml and an
LVESV of 71 ml after surgery, suggesting that pa-
tients with a preserved WMI and mild LV dilation
may not be good candidates for our procedure. The
optimal timing for our procedure and responders
warrants investigation in a larger population.
Study limitations. There are several limitations to
this study. First, the sample size of this study was
small, but beneficial therapeutic effects of SVR on
the WMI were demonstrated and statistically
proved to be significant. Second, noninvasive as-
sessment of external work estimated by the SVLVOT
could be underestimated in proportion to the mag-
nitude of mitral regurgitating volume. Although we
did not measure the mitral regurgitant WMI, the
previous study demonstrated that regurgitant workGroup. Effects of enalapril on mortal- in functional mitralpatients with mitral regurgitation (34  19 ml),
indicating that the effects of mitral repair on the total
WMI might be minimal even when the regurgitant
WMI was considered in the present study. However,
the WMI computed by the SVLVOT and Kmono
would be useful, especially in clinical practice.
However, the WMI in DCM was likely underesti-
mated compared with that in ICM because mitral
regurgitation in DCM was more severe than that in
ICM. The effect of mitral regurgitation on the
WMI in severe heart failure needs to be investi-
gated in a large population. Third, cardiac function
and oxidative metabolism were examined at 1
month after surgery in the present study. Long-
term results may be required to determine the
changes in cardiac oxidative metabolism and effi-
ciency more clearly. Fourth, -blockers were dis-
continued during this study because administration
of -blockers often worsens heart failure in the
perioperative period. This change in medication
may complicate the effects of SVR on cardiac
efficiency. However, the rate-pressure product did
not change after SVR, suggesting that the effects of
the discontinuing of -blockers on myocardial ox-
idative metabolism might be small.
C O N C L U S I O N S
LV volume reduction and correction of mitral regur-
gitation by integrated surgery with SVR and MCR
significantly improved cardiac efficiency in patients
with end-stage heart failure, which was observed in
both nonischemic and ischemic etiologies.
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